Float Short %

2.43

Margin Of Safety %

-1

Put/Call OI Ratio

1.21

EPS Next Q Diff

0.25

EPS Last/This Y

0.57

EPS This/Next Y

0.49

Price

86.32

Target Price

100.36

Analyst Recom

1.47

Performance Q

24.27

Relative Volume

1.09

Beta

1.45

Ticker: DXCM

19 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-06-02	DXCM	85.54	0.86	0.97	133518
2025-06-03	DXCM	86.87	0.86	0.21	135275
2025-06-04	DXCM	85.61	0.85	3.05	135997
2025-06-05	DXCM	85.75	0.86	24.45	136607
2025-06-06	DXCM	86.65	0.91	2.67	140815
2025-06-09	DXCM	85.73	0.95	0.51	139703
2025-06-10	DXCM	84.82	0.95	3.84	140386
2025-06-11	DXCM	83.11	1.01	0.85	146814
2025-06-12	DXCM	82.85	1.01	2.59	147697
2025-06-13	DXCM	81.96	1.01	2.23	148179
2025-06-16	DXCM	83.08	1.02	0.90	147587
2025-06-17	DXCM	81.8	1.01	5.76	148267
2025-06-18	DXCM	81	1.02	10.38	149642
2025-06-20	DXCM	80.02	1.02	4.36	150360
2025-06-23	DXCM	79.83	1.21	3.14	116417
2025-06-24	DXCM	87.69	1.24	0.56	119632
2025-06-25	DXCM	84.71	1.21	0.81	126693
2025-06-26	DXCM	85.05	1.21	0.97	128705
2025-06-27	DXCM	86.34	1.21	0.87	129026
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-06-02	DXCM	85.53	3.6	52.3	2.02
2025-06-03	DXCM	86.79	3.6	66.9	2.02
2025-06-04	DXCM	85.65	3.6	44.2	2.02
2025-06-05	DXCM	85.74	3.6	56.1	2.02
2025-06-06	DXCM	86.64	3.6	63.3	2.02
2025-06-09	DXCM	85.68	3.6	45.6	2.02
2025-06-10	DXCM	84.80	3.6	46.5	2.02
2025-06-11	DXCM	83.11	3.6	38.5	2.02
2025-06-12	DXCM	82.85	3.6	53.5	2.02
2025-06-13	DXCM	81.93	3.6	45.8	2.02
2025-06-16	DXCM	83.32	3.6	67.9	2.02
2025-06-17	DXCM	81.81	3.6	43.2	2.03
2025-06-18	DXCM	81.01	3.6	46.7	2.03
2025-06-20	DXCM	80.00	3.6	44.8	2.03
2025-06-23	DXCM	79.83	3.6	53.2	2.03
2025-06-24	DXCM	87.58	3.2	133.2	2.03
2025-06-25	DXCM	84.66	3.2	28.0	2.03
2025-06-26	DXCM	85.04	3.2	58.5	2.03
2025-06-27	DXCM	86.32	3.2	67.0	2.03
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-06-02	DXCM	-2.60	1.41	2.92
2025-06-03	DXCM	-2.58	1.41	2.92
2025-06-04	DXCM	-2.58	1.41	2.92
2025-06-05	DXCM	-2.58	1.41	2.92
2025-06-06	DXCM	-2.58	1.41	2.92
2025-06-09	DXCM	-2.58	1.41	2.92
2025-06-10	DXCM	-2.60	1.41	2.92
2025-06-11	DXCM	-2.60	1.41	2.69
2025-06-12	DXCM	-2.60	1.41	2.69
2025-06-13	DXCM	-2.60	1.41	2.69
2025-06-16	DXCM	-2.60	1.40	2.69
2025-06-18	DXCM	-2.71	1.40	2.69
2025-06-20	DXCM	-2.71	1.40	2.69
2025-06-23	DXCM	-2.71	1.44	2.69
2025-06-24	DXCM	-2.71	1.44	2.69
2025-06-25	DXCM	-2.71	1.44	2.69
2025-06-26	DXCM	-2.78	1.44	2.43
2025-06-27	DXCM	-2.78	1.44	2.43
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.32

Avg. EPS Est. Current Quarter

0.44

Avg. EPS Est. Next Quarter

0.57

Insider Transactions

-2.78

Institutional Transactions

1.44

Beta

1.45

Average Sales Estimate Current Quarter

1125

Average Sales Estimate Next Quarter

1169

Fair Value

85.83

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

47.6

Max Drawdown 5-Year %

-63.3

Target Price

100.36

P/E

64.81

Forward P/E

33.95

PEG

2.7

P/S

8.16

P/B

14.93

P/Free Cash Flow

58.85

EPS

1.33

Average EPS Est. Cur. Y

2.03

EPS Next Y. (Est.)

2.52

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

12.9

Relative Volume

1.09

Return on Equity vs Sector %

-0.3

Return on Equity vs Industry %

5.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

DexCom, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 10200

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Stelo, a new over-the-counter glucose biosensor designed for adults with prediabetes and Type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

stock quote shares DXCM – DexCom, Inc. Stock Price stock today

news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch DXCM – DexCom, Inc. yahoo finance google finance

stock history DXCM – DexCom, Inc. invest stock market

stock prices DXCM premarket after hours

ticker DXCM fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: DXCM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y